Nobuo Shinohara

Hokkaido University — Japan

Medicine · Health Sciences

50h-index9.1kcitations552works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(118), Bladder and Urothelial Cancer Treatments(115), Urinary and Genital Oncology Studies(60), Urological Disorders and Treatments(47), Prostate Cancer Diagnosis and Treatment(41)

Publications551 total

Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen project
npj Precision Oncology·2025Open Access
Maternal Microchimerism Is Uncommon in Patients with Hypospadias
Sexual Development·2025
<scp>GWAS</scp> Identifies <scp>SNPs</scp> Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab
Cancer Science·2025Open Access
External validation of a motion capture-based surgical skill assessment system in laparoscopic simulation training environments
Surgical Endoscopy·2025· 3 citedOpen Access
Enhanced SARS-CoV-2 BA.2.86 Neutralization After BA.5 Infection in Vaccinated Kidney Transplant Recipients
Transplantation Proceedings·2025
MP28-07 MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELLS EXHIBIT PRIMARY RESISTANCE TO NIVOLUMAB PLUS IPILIMUMAB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
The Journal of Urology·2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study
JCO Clinical Cancer Informatics·2025Open Access
Current Landscape of Urological Surgical Training: A Needs Assessment Survey in Japan
International Journal of Urology·2025· 1 citedOpen Access
Development of a Hybrid Measurement System for Surgical Instrument Motion of Laparoscopic Surgery
IEEE Transactions on Medical Robotics and Bionics·2025
Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment
International Journal of Clinical Oncology·2025Open Access
Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification
International Journal of Clinical Oncology·2025Open Access
External validation of previously reported prognostic classifications for patients treated with second-line axitinib after immuno-oncology combination therapy for advanced renal cell carcinoma: JUOG retrospective study.
Journal of Clinical Oncology·2025
Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations
BMC Cancer·2025· 1 citedOpen Access
Inadequate effect of rituximab alone as desensitization to kidney transplant recipients with low titer of preformed donor‐specific ant‐<scp>HLA</scp> antibodies
International Journal of Urology·2025· 1 cited
Genomic characterization of metastatic patterns in prostate cancer using circulating tumor DNA data from the SCRUM-Japan MONSTAR SCREEN project
The Journal of Liquid Biopsy·2024Open Access
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
International Journal of Clinical Oncology·2024· 4 citedOpen Access
Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization
Human Vaccines & Immunotherapeutics·2024· 1 citedOpen Access
862 Analysis of antigen specificity of tumor infiltrating B lymphocytes in tertiary lymphoid structures positive melanoma
Regular and Young Investigator Award Abstracts·2024Open Access
Comorbidities in Japanese testicular cancer survivors: A multi‐institutional, cross‐sectional study
International Journal of Urology·2024· 1 citedOpen Access
247.8: Analysis of T-cell alloantigen response via a direct pathway in kidney transplant recipients with donor-specific antibodies.
Transplantation·2024
page 1 of 28Next →

Frequent Co-authors

Katsuya Nonomura(20), Takashige Abe(11), Toru Harabayashi(10), Tomohiko Koyanagi(9), Yasuhiro Hida(7), Takahiro Osawa(7), Ataru Sazawa(7), Hiroki Shirato(6), Hirotsugu Uemura(6), Seiichiro Ozono(6), Seiji Naito(6), Yoshihiko Tomita(6), Noritaka Ohga(6), Masanobu Shindoh(6), Nako Maishi(6), Satoru Maruyama(6), Shinichi Shimizu(5), Kei Kitamura(5), Kazuo Miyasaka(5), Rikiya Onimaru(4)